NSE filing, NSE: CHANDAN. Summary written from the filing by ALFA Finder's alert engine.
Chandan Healthcare Ltd: key numbers
- Share price
- ₹224.20
- Market cap
- ₹576.2 Cr
- Revenue (annual)
- ₹276.4 Cr
- Net profit (annual)
- ₹28.55 Cr
- P/E (TTM)
- 20.2×Sector 51.1×
- Promoter holding
- 47.20%-2.41% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandan Healthcare Ltd
All →Chandan Healthcare Annual General Meeting
Chandan Healthcare calls an EGM on 20 November 2026 to approve related party transactions, including director guarantees. E-voting runs 17 to 19 November 2026.
Chandan Healthcare Results Update
Chandan Healthcare's Q2 FY2027 revenue from diagnostics grew 46.66% YoY to Rs. 56.38 Crore, while its franchise network expanded to 685 locations.
- franchise expansion
- 410.0 franchises
Chandan Healthcare Debt & Borrowing: ₹5.22 Cr
Chandan Healthcare Limited secured a ₹5.22 Crore medical equipment loan from ICICI Bank for purchasing a 128-slice CT scanner.
- Value
- ₹5.22 Cr
- Execution
- 60 months
Chandan Healthcare Annual General Meeting
Chandan Healthcare Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting covered routine business, including financial adoption and board appointments.
Chandan Healthcare Capital Structure Change
Chandan Healthcare allotted 6,50,000 equity shares upon conversion of warrants for ₹15.21 Crore consideration.
- Value
- ₹15.21 Cr
Chandan Healthcare Capacity Expansion
Chandan Healthcare scaled its diagnostic franchise network to 500+ centres, reaching a total of 568+ centres. It targets 1,000 centres by FY27-end and 3,000 in two years.
- diagnostic franchise collection centres
- 500 franchise centres
Other management change announcements
All →Sagarsoft (India) Management Change
Sagarsoft (India) appointed Ms. Arcot Ganeshan Monisha as Company Secretary and Compliance Officer, designated as KMP, effective 28 October 2026. Details are provided per Regulation 30 in the annexure.
Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Aeroflex Industries Management Change
Aeroflex Industries reports Drashti Bhil's change from Deputy CFO to CFO, plus Mustafa Kachwala's tenure completion as CFO effective 27 November 2026. Management reshuffle with no money or business event.
Chandra Prabhu International Management Change
Chandra Prabhu International resignation of Mrs. Vandana Singh, Additional Director, accepted effective close of business 28 October 2026. Filed as per SEBI Master Circular disclosure requirements.
Hexagon Nutrition Management Change
Hexagon Nutrition shareholders approved Arun Purushottam Kelkar as Executive Director and Chairman, effective October 28, 2026. He has been with the company since its incorporation.
- Execution
- 5 years
Mercury Laboratories Management Change
Mercury Laboratories disclosed the cessation of Manager-HR Jaydeepsinh Raj, effective October 28, 2026. The employee stopped reporting for duty without prior intimation to the company.